• Study on Preventing Infections After Esophageal Cancer Surgery Using Colistin Sulfate, Tobramycin, and Amphotericin B in Patients with Resectable Esophageal Cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    Belgium The Netherlands
  • Study on Beta-Blockers for Patients with Takotsubo Syndrome: Evaluating Selective, Non-Selective, and Alpha-Beta Blocking Agents

    Recruiting

    3 1 1 1
    Spain
  • Study of Dostarlimab for Patients with Untreated Locally Advanced Rectal Cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy The Netherlands Spain
  • Study on the Effectiveness of Ozanimod for Children with Moderate to Severe Ulcerative Colitis Not Responding to Usual Treatment

    Recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium France Germany Poland Spain
  • Long-term Safety and Efficacy Study of JR-141 (Pabinafusp Alfa) for Male Patients with Hunter Syndrome (Mucopolysaccharidosis II)

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Poland Spain
  • Study on Durvalumab, Etoposide, and Platinum Drug Combination for First-Line Treatment of Advanced Large-Cell Neuroendocrine Lung Cancer Patients

    Recruiting

    2 1 1 1
    Investigated diseases:
    France
  • Study on Azacitidine for Patients with Myelodysplastic Syndrome After Stem Cell Transplantation

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark Finland Norway Sweden
  • Study Comparing PENG Block and Lumbar Plexus Block for Pain Relief and Mobility After Hip Replacement Using Levobupivacaine and Sodium Chloride in Hip Surgery Patients

    Recruiting

    3 1 1
    Investigated diseases:
    Spain
  • Study on Human Cancellous Bone for Partial Meniscal Replacement in Patients with Incomplete Meniscal Loss

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study of Axitinib and Nivolumab for Patients with Metastatic Renal Cell Carcinoma Not Responding Completely to Initial Treatment

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Spain

powered by